Bank Julius Baer & Co
EDIT icon

Bank Julius Baer & Co’s Editas Medicine EDIT Stock Holding History

Bank Julius Baer & Co’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,384
Closed -$97K – 837
2020
Q4 		$97K Buy
+1,384
New +$56.9K ﹤0.01% 633

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank Julius Baer & Co's EDIT Position: Q1 2021 in Review

Bank Julius Baer & Co sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 1,384 shares — an estimated $97K sold.

Bank Julius Baer & Co first reported a position in EDIT in Q4 2020 and held it in 1 quarter. The position peaked at $97K in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • Bank Julius Baer & Co reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,384 Editas Medicine shares in Q1 2021, an estimated $97K.
  • Bank Julius Baer & Co first reported a position in Editas Medicine in Q4 2020 and held it in 1 quarter.
  • Bank Julius Baer & Co's Editas Medicine position peaked at $97K in Q4 2020.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.